
Inside Berkshire Hathaway, some investors think legendary CEO Warren Buffett may be laying the groundwork for a blockbuster business opportunity, spawned from the health care venture he recently formed with the leaders of Amazon and JPMorgan Chase.
While most of the national discussion about the high-profile venture has focused on its potential to reshape the U.S. health care system, interviews with two long-time Berkshire shareholders show that within Buffett World, it’s also seen as a chance to develop profit-making lines of business and new investment ideas.
What is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Thx